Interim Report Second Quarter 2022
NASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENOSTENOCARE A/S (“STENOCARE”) today announces its results for the period 01.01.2022 – 30.06.2022. The report, which has not been reviewed by the Company’s auditors, is attached to this release and is also available on https://stenocare.com/investor-relations/ Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments: We are back in business in Denmark. Q2 2022 marked a milestone that we have been working hard to realize since 2019. We imported and began sales of our new THC Oil products to patients in Denmark. For Stenocare this